These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22555039)

  • 21. Reasons, perceived outcomes and characteristics of second-opinion seekers: are there differences in private vs. public settings?
    Shmueli L; Davidovitch N; Pliskin JS; Hekselman I; Balicer RD; Greenfield G
    BMC Health Serv Res; 2019 Apr; 19(1):238. PubMed ID: 31014323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
    Koppie TM; Grossfeld GD; Miller D; Yu J; Stier D; Broering JM; Lubeck D; Henning JM; Flanders SC; Carroll PR
    J Urol; 2000 Jul; 164(1):81-8. PubMed ID: 10840429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.
    Recker F; Kwiatkowski MK; Huber A; Stamm B; Lehmann K; Tscholl R
    J Urol; 2001 Sep; 166(3):851-5. PubMed ID: 11490232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Race as an independent predictor of outcome after treatment for localized prostate cancer.
    Sohayda CJ; Kupelian PA; Altsman KA; Klein EA
    J Urol; 1999 Oct; 162(4):1331-6. PubMed ID: 10492191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current trends in diagnostic and therapeutic principles for prostate cancer in Japan.
    Okihara K; Shiraishi T; Ukimura O; Mizutani Y; Kawauchi A; Miki T
    Int J Clin Oncol; 2008 Jun; 13(3):239-43. PubMed ID: 18553234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
    Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of salvage therapy for prostate cancer.
    Johnstone PA; Booth R; Riffenburgh RH; Amling CL; Kane CJ; Moul JW
    Prostate Cancer Prostatic Dis; 2002; 5(2):136-43. PubMed ID: 12497004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
    J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database.
    Vesey SG; McCabe JE; Hounsome L; Fowler S
    BJU Int; 2012 Feb; 109(3):346-54. PubMed ID: 21771246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer in Victoria in 1993: patterns of reported management.
    Frydenberg M; Giles GG; Mameghan H; Thursfield VJ; Millar J; Wheelahan JB; Bolton DM; Syme RR
    Med J Aust; 2000 Mar; 172(6):270-4. PubMed ID: 10860092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
    Moul JW; Connelly RR; Lubeck DP; Bauer JJ; Sun L; Flanders SC; Grossfeld GD; Carroll PR
    J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
    Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG
    Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study.
    Gilliland FD; Hoffman RM; Hamilton A; Albertsen P; Eley JW; Harlan L; Stanford JL; Hunt WC; Potosky A; Stephenson RA
    J Urol; 1999 Oct; 162(4):1341-5. PubMed ID: 10492193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who is implicated in the care of digestive cancers? A population-based study over a 25-year period.
    Vernet C; Lepage C; Lejeune C; Faivre J; Bouvier AM
    Gastroenterol Clin Biol; 2006 Nov; 30(11):1251-5. PubMed ID: 17185967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
    J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.